MARKET WIRE NEWS

Innovent inks $11.4 billion cancer drug partnership with Japan's Takeda

Source: SeekingAlpha

2025-10-22 01:55:39 ET

More on Innovent Biologics, Takeda Pharmaceutical

Read the full article on Seeking Alpha

For further details see:

Innovent inks $11.4 billion cancer drug partnership with Japan's Takeda
Innovent Biologics Inc

NASDAQ: IVBXF

IVBXF Trading

-1.19% G/L:

$9.95 Last:

8,095 Volume:

$10 Open:

mwn-app Ad 300

IVBXF Latest News

IVBXF Stock Data

$18,437,734,417
1,622,682,897
N/A
N/A
Biotechnology & Life Sciences
Healthcare
CN

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App